{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:47:22Z","timestamp":1758991642108,"version":"3.44.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4804,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.fertnstert.2008.07.1711","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T18:27:31Z","timestamp":1220812051000},"page":"1466-1468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S","title":["What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?"],"prefix":"10.1016","volume":"91","author":[{"given":"Raoul","family":"Orvieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simion","family":"Meltcer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Homburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravit","family":"Nahum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Rabinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Ashkenazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.07.1711_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)58017-0","article-title":"Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization","volume":"65","author":"Buyalos","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0015-0282(16)57793-0","article-title":"Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient","volume":"64","author":"Ashkenazi","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/oxfordjournals.humrep.a137189","article-title":"The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility","volume":"5","author":"Dor","year":"1990","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0015-0282(16)55086-9","article-title":"The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins","volume":"57","author":"Urman","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","article-title":"GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis","volume":"13","author":"Griesinger","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib9","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/humrep\/12.11.2359","article-title":"Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients","volume":"12","author":"Damario","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Gonadotrophin releasing hormone antagonists for assisted conception: a Cochrane review","volume":"14","author":"Al-Inany","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/humrep\/deh613","article-title":"Can we eliminate severe ovarian hyperstimulation syndrome?","volume":"20","author":"Orvieto","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib12","first-page":"197","article-title":"GnRH agonist versus GnRH antagonist in ovarian stimulation: Is the emperor naked?","volume":"33","author":"Orvieto","year":"2006","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2007.10.022","article-title":"GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity","author":"Orvieto","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.07.1711_bib14","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0015-0282(02)03157-6","article-title":"The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation","volume":"77","author":"Shoham","year":"2002","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208014866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208014866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:34:46Z","timestamp":1758008086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208014866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0015028208014866"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.07.1711","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.07.1711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}